Cargando…

Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea

BACKGROUND: Histologic grade is the most important predictor of the clinical outcome of non-muscle invasive (Ta, T1) papillary urothelial carcinoma (NMIPUCa), but its ambiguous criteria diminish its power to predict recurrence/progression for individual patients. We attempted to find an objective an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Ji Eun, Cho, Nam Hoon, Choi, Yeong-Jin, Lim, So Dug, Cho, Yong Mee, Jun, Sun Young, Park, Sanghui, Kim, Young A., Kim, Sung-Sun, Choe, Mi Sun, Lee, Jung-dong, Kang, Dae Yong, Ro, Jae Y., Kim, Hyun-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525253/
https://www.ncbi.nlm.nih.gov/pubmed/28738880
http://dx.doi.org/10.1186/s13000-017-0639-y
_version_ 1783252609644101632
author Kwon, Ji Eun
Cho, Nam Hoon
Choi, Yeong-Jin
Lim, So Dug
Cho, Yong Mee
Jun, Sun Young
Park, Sanghui
Kim, Young A.
Kim, Sung-Sun
Choe, Mi Sun
Lee, Jung-dong
Kang, Dae Yong
Ro, Jae Y.
Kim, Hyun-Jung
author_facet Kwon, Ji Eun
Cho, Nam Hoon
Choi, Yeong-Jin
Lim, So Dug
Cho, Yong Mee
Jun, Sun Young
Park, Sanghui
Kim, Young A.
Kim, Sung-Sun
Choe, Mi Sun
Lee, Jung-dong
Kang, Dae Yong
Ro, Jae Y.
Kim, Hyun-Jung
author_sort Kwon, Ji Eun
collection PubMed
description BACKGROUND: Histologic grade is the most important predictor of the clinical outcome of non-muscle invasive (Ta, T1) papillary urothelial carcinoma (NMIPUCa), but its ambiguous criteria diminish its power to predict recurrence/progression for individual patients. We attempted to find an objective and reproducible histologic predictor of NMIPUCa that correlates well with the clinical outcome. METHODS: A total of 296 PUCas were collected from the Departments of Surgical Pathology of 11 institutions in South Korea. The clinical outcome was grouped into no event (NE), recurrence (R), and progression (P) categories. All 25 histological parameters were numerically redefined. The clinical pathology of each case was reviewed individually by 11 pathologists from 11 institutions based on the 2004 WHO criteria and afterwards blindly evaluated by two participants, based on our proposed parameters. Univariate and multivariate logistic regression analyses were performed using the R software package. RESULTS: The level of mitoses was the most reliable parameter for predicting the clinical outcome. We propose a four-tiered grading system based on mitotic count (> 10/10 high-power fields), nuclear pleomorphism (smallest-to-largest ratio of tumor nuclei >20), presence of divergent histology, and capillary proliferation (> 20 capillary lumina per papillary core). CONCLUSIONS: The level of mitoses at the initial bladder biopsy and transurethral resection (TUR) specimen appeared to be an independent predictor of the Ta PUCa outcome. Other parameters include the number of mitoses, nuclear pleomorphism, divergent histology, and capillary proliferation within the fibrovascular core. These findings may improve selection of patients for a therapeutic strategy as compared to previous grading systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13000-017-0639-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5525253
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55252532017-07-26 Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea Kwon, Ji Eun Cho, Nam Hoon Choi, Yeong-Jin Lim, So Dug Cho, Yong Mee Jun, Sun Young Park, Sanghui Kim, Young A. Kim, Sung-Sun Choe, Mi Sun Lee, Jung-dong Kang, Dae Yong Ro, Jae Y. Kim, Hyun-Jung Diagn Pathol Research BACKGROUND: Histologic grade is the most important predictor of the clinical outcome of non-muscle invasive (Ta, T1) papillary urothelial carcinoma (NMIPUCa), but its ambiguous criteria diminish its power to predict recurrence/progression for individual patients. We attempted to find an objective and reproducible histologic predictor of NMIPUCa that correlates well with the clinical outcome. METHODS: A total of 296 PUCas were collected from the Departments of Surgical Pathology of 11 institutions in South Korea. The clinical outcome was grouped into no event (NE), recurrence (R), and progression (P) categories. All 25 histological parameters were numerically redefined. The clinical pathology of each case was reviewed individually by 11 pathologists from 11 institutions based on the 2004 WHO criteria and afterwards blindly evaluated by two participants, based on our proposed parameters. Univariate and multivariate logistic regression analyses were performed using the R software package. RESULTS: The level of mitoses was the most reliable parameter for predicting the clinical outcome. We propose a four-tiered grading system based on mitotic count (> 10/10 high-power fields), nuclear pleomorphism (smallest-to-largest ratio of tumor nuclei >20), presence of divergent histology, and capillary proliferation (> 20 capillary lumina per papillary core). CONCLUSIONS: The level of mitoses at the initial bladder biopsy and transurethral resection (TUR) specimen appeared to be an independent predictor of the Ta PUCa outcome. Other parameters include the number of mitoses, nuclear pleomorphism, divergent histology, and capillary proliferation within the fibrovascular core. These findings may improve selection of patients for a therapeutic strategy as compared to previous grading systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13000-017-0639-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-24 /pmc/articles/PMC5525253/ /pubmed/28738880 http://dx.doi.org/10.1186/s13000-017-0639-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kwon, Ji Eun
Cho, Nam Hoon
Choi, Yeong-Jin
Lim, So Dug
Cho, Yong Mee
Jun, Sun Young
Park, Sanghui
Kim, Young A.
Kim, Sung-Sun
Choe, Mi Sun
Lee, Jung-dong
Kang, Dae Yong
Ro, Jae Y.
Kim, Hyun-Jung
Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea
title Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea
title_full Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea
title_fullStr Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea
title_full_unstemmed Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea
title_short Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea
title_sort level of mitoses in non-muscle invasive papillary urothelial carcinomas (pta and pt1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in south korea
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525253/
https://www.ncbi.nlm.nih.gov/pubmed/28738880
http://dx.doi.org/10.1186/s13000-017-0639-y
work_keys_str_mv AT kwonjieun levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT chonamhoon levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT choiyeongjin levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT limsodug levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT choyongmee levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT junsunyoung levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT parksanghui levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT kimyounga levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT kimsungsun levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT choemisun levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT leejungdong levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT kangdaeyong levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT rojaey levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea
AT kimhyunjung levelofmitosesinnonmuscleinvasivepapillaryurothelialcarcinomasptaandpt1atinitialbladderbiopsyisasimpleandpowerfulpredictorofclinicaloutcomeamulticenterstudyinsouthkorea